ACE2 and COVID-19: Mechanistically, we showed that the SARS‐CoV‐2 spike protein, guided by the mRNA COVID‐19 vaccine, interferes with insulin signaling by binding to angiotensin‐converting enzyme 2, TLR4, and ER.